Archives of Pediatric Infectious Diseases

Published by: Kowsar

Prevalence of Vancomycin-resistant Enterococci Colonization, and Susceptibility to linezolid in Pediatric Intensive Care Units of a Referral Pediatric Center in Tehran, Iran

Alireza Nateghian 1 , Seyed Mohammad Ghasemi Ahari 1 , Arash Lahouti Harahdashti 1 , Masoumeh Navidnia 2 and Mitra Mehrazma 3 , *
Authors Information
1 Ali-Asghar Children’s Hospital, Iran University of Medical Sciences, Tehran, IR Iran
2 Pediatric Infections Research Center, Mofid Children’s Hospital, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran
3 Oncopathology Research Center, Ali-Asghar Children’s Hospital, Iran University of Medical Sciences, Tehran, IR Iran
Article information
  • Archives of Pediatric Infectious Diseases: October 01, 2014, 2 (4); e16970
  • Published Online: October 24, 2014
  • Article Type: Research Article
  • Received: December 17, 2013
  • Revised: January 21, 2014
  • Accepted: February 21, 2014
  • DOI: 10.5812/pedinfect.16970

To Cite: Nateghian A, Ghasemi Ahari S M, Lahouti Harahdashti A, Navidnia M, Mehrazma M. Prevalence of Vancomycin-resistant Enterococci Colonization, and Susceptibility to linezolid in Pediatric Intensive Care Units of a Referral Pediatric Center in Tehran, Iran, Arch Pediatr Infect Dis. 2014 ; 2(4):e16970. doi: 10.5812/pedinfect.16970.

Abstract
Copyright © 2014, Pediartric Infections Research Center. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Bourdon N, Fines-Guyon M, Thiolet JM, Maugat S, Coignard B, Leclercq R, et al. Changing trends in vancomycin-resistant enterococci in French hospitals, 2001-08. J Antimicrob Chemother. 2011; 66(4): 713-21[DOI][PubMed]
  • 2. Leclercq R. Epidemiological and resistance issues in multidrug-resistant staphylococci and enterococci. Clin Microbiol Infec. 2009; 15(3): 224-31[DOI]
  • 3. Gomez-Gil R, Romero-Gomez MP, Garcia-Arias A, Ubeda MG, Busselo MS, Cisterna R, et al. Nosocomial outbreak of linezolid-resistant Enterococcus faecalis infection in a tertiary care hospital. Diagn Microbiol Infect Dis. 2009; 65(2): 175-9[DOI][PubMed]
  • 4. Low DE, Keller N, Barth A, Jones RN. Clinical prevalence, antimicrobial susceptibility, and geographic resistance patterns of enterococci: results from the SENTRY Antimicrobial Surveillance Program, 1997-1999. Clin Infect Dis. 2001; 32 Suppl 2-45[DOI][PubMed]
  • 5. Humphreys H, Dolan V, Sexton T, Conlon P, Rajan L, Creamer E, et al. Implications of colonization of vancomycin-resistant enterococci (VRE) in renal dialysis patients. Learning to live with it? J Hosp Infect. 2004; 58(1): 28-33[DOI][PubMed]
  • 6. Souli M, Sakka V, Galani I, Antoniadou A, Galani L, Siafakas N, et al. Colonisation with vancomycin- and linezolid-resistant Enterococcus faecium in a university hospital: molecular epidemiology and risk factor analysis. Int J Antimicrob Agents. 2009; 33(2): 137-42[DOI][PubMed]
  • 7. Kaatz GW, Seo SM. In vitro activities of oxazolidinone compounds U100592 and U100766 against Staphylococcus aureus and Staphylococcus epidermidis. Antimicrob Agents Chemother. 1996; 40(3): 799-801[PubMed]
  • 8. Velissariou IM. Linezolid in children: recent patents and advances. Recent Pat Antiinfect Drug Discov. 2007; 2(1): 73-7[PubMed]
  • 9. Schulte B, Heininger A, Autenrieth IB, Wolz C. Emergence of increasing linezolid-resistance in enterococci in a post-outbreak situation with vancomycin-resistant Enterococcus faecium. Epidemiol Infect. 2008; 136(8): 1131-3[DOI][PubMed]
  • 10. Werner G, Bartel M, Wellinghausen N, Essig A, Klare I, Witte W, et al. Detection of mutations conferring resistance to linezolid in Enterococcus spp. by fluorescence in situ hybridization. J Clin Microbiol. 2007; 45(10): 3421-3[DOI][PubMed]
  • 11. Yoon YK, Sim HS, Kim JY, Park DW, Sohn JW, Roh KH, et al. Epidemiology and control of an outbreak of vancomycin-resistant enterococci in the intensive care units. Yonsei Med J. 2009; 50(5): 637-43[DOI][PubMed]
  • 12. Performance Standards for Antimicrobial Susceptibility Testing: Twenty-second Informational Supplement. 2012;
  • 13. Wang JT, Chang SC, Wang HY, Chen PC, Shiau YR, Lauderdale TL, et al. High rates of multidrug resistance in Enterococcus faecalis and E. faecium isolated from inpatients and outpatients in Taiwan. Diagn Microbiol Infect Dis. 2013; 75(4): 406-11[DOI][PubMed]
  • 14. Song JY, Cheong HJ, Jo YM, Choi WS, Noh JY, Heo JY, et al. Vancomycin-resistant Enterococcus colonization before admission to the intensive care unit: a clinico-epidemiologic analysis. Am J Infect Control. 2009; 37(9): 734-40[DOI][PubMed]
  • 15. Littvik AM, Lopez TN, Gonzalez SE, Fernandez CM, Pavan JV. Colonization with vancomycin-resistant enterococci (VRE) in intensive care unit patients in Cordoba City, Argentina. Rev Argent Microbiol. 2006; 38(1): 28-30[PubMed]
  • 16. Warren DK, Kollef MH, Seiler SM, Fridkin SK, Fraser VJ. The Epidemiology of Vancomycin‐Resistant Enterococcus Colonization in a Medical Intensive Care Unit. Infect Control and HospEpidemiol. 2003; 24(4): 257-63[DOI]
  • 17. Yis R, Aslan S, Citak C, Degirmenci S. [Evaluation of vancomycin-resistant enterococcus colonization at Gaziantep Children's Hospital, Turkey]. Mikrobiyol Bul. 2011; 45(4): 646-54[PubMed]
  • 18. Singh N, Leger MM, Campbell J, Short B, Campos JM. Control of vancomycin-resistant enterococci in the neonatal intensive care unit. Infect Control Hosp Epidemiol. 2005; 26(7): 646-9[DOI][PubMed]
  • 19. d'Azevedo PA, Santiago KA, Furtado GH, Xavier DB, Pignatari AC, Titze-de-Almeida R. Rapid detection of vancomycin-resistant enterococci (VRE) in rectal samples from patients admitted to intensive care units. Braz J Infect Dis. 2009; 13(4): 289-93[PubMed]
  • 20. D'Agata EM, Gautam S, Green WK, Tang YW. High rate of false-negative results of the rectal swab culture method in detection of gastrointestinal colonization with vancomycin-resistant enterococci. Clin Infect Dis. 2002; 34(2): 167-72[DOI][PubMed]
  • 21. Nateghian A, Robinson JL, Arjmandi K, Vosough P, Karimi A, Behzad A, et al. Epidemiology of vancomycin-resistant enterococci in children with acute lymphoblastic leukemia at two referral centers in Tehran, Iran: a descriptive study. Int J Infect Dis. 2011; 15(5)-5[DOI][PubMed]
  • 22. Cho SY, Lee DG, Choi SM, Kwon JC, Kim SH, Choi JK, et al. Impact of vancomycin resistance on mortality in neutropenic patients with enterococcal bloodstream infection: a retrospective study. BMC Infect Dis. 2013; 13: 504[DOI][PubMed]
  • 23. Yameen MA, Iram S, Mannan A, Khan SA, Akhtar N. Nasal and perirectal colonization of vancomycin sensitive and resistant enterococci in patients of paediatrics ICU (PICU) of tertiary health care facilities. BMC Infect Dis. 2013; 13: 156[DOI][PubMed]
  • 24. Chitnis S, Katara G, Hemvani N, Pareek S, Chitnis DS. In vitro activity of daptomycin & linezolid against methicillin resistant Staphylococcus aureus & vancomycin resistant enterococci isolated from hospitalized cases in Central India. Indian J Med Res. 2013; 137(1): 191-6[PubMed]
  • 25. Suntharam N, Lankford MG, Trick WE, Peterson LR, Noskin GA. Risk factors for acquisition of vancomycin-resistant enterococci among hematology-oncology patients. Diagn Microbiol Infect Dis. 2002; 43(3): 183-8[PubMed]
  • 26. Askarian M, Afkhamzadeh R, Monabbati A, Daxboeck F, Assadian O. Risk factors for rectal colonization with vancomycin-resistant enterococci in Shiraz, Iran. Int J Infect Dis. 2008; 12(2): 171-5[DOI][PubMed]
  • 27. Altoparlak U, Koca O, Ozkurt Z, Akcay MN. Incidence and risk factors of vancomycin-resistant enterococcus colonization in burn unit patients. Burns. 2011; 37(1): 49-53[DOI][PubMed]
  • 28. Karki S, Houston L, Land G, Bass P, Kehoe R, Borrell S, et al. Prevalence and risk factors for VRE colonisation in a tertiary hospital in Melbourne, Australia: a cross sectional study. Antimicrob Resist Infect Control. 2012; 1(1): 31[DOI][PubMed]
  • 29. Pan SC, Wang JT, Chen YC, Chang YY, Chen ML, Chang SC. Incidence of and risk factors for infection or colonization of vancomycin-resistant enterococci in patients in the intensive care unit. PLoS One. 2012; 7(10)[DOI][PubMed]
  • 30. Furtado GH, Martins ST, Coutinho AP, Wey SB, Medeiros EA. Prevalence and factors associated with rectal vancomycin-resistant enterococci colonization in two intensive care units in Sao Paulo, Brazil. Braz J Infect Dis. 2005; 9(1): 64-9[PubMed]
  • 31. Dan M, Poch F, Leibson L, Smetana S, Priel I. Rectal colonization with vancomycin-resistant enterococci among high-risk patients in an Israeli hospital. J Hosp Infect. 1999; 43(3): 231-8[DOI][PubMed]
  • 32. Hagen EA, Lautenbach E, Olthoff K, Blumberg EA. Low prevalence of colonization with vancomycin-resistant Enterococcus in patients awaiting liver transplantation. Am J Transplant. 2003; 3(7): 902-5[PubMed]
  • 33. Salgado CD. The risk of developing a vancomycin-resistant Enterococcus bloodstream infection for colonized patients. Am J Infect Control. 2008; 36(10)-8[DOI][PubMed]
  • 34. Sakka V, Tsiodras S, Galani L, Antoniadou A, Souli M, Galani I, et al. Risk-factors and predictors of mortality in patients colonised with vancomycin-resistant enterococci. Clin Microbiol Infect. 2008; 14(1): 14-21[DOI][PubMed]
  • 35. Ergaz Z, Arad I, Bar-Oz B, Peleg O, Benenson S, Minster N, et al. Elimination of vancomycin-resistant enterococci from a neonatal intensive care unit following an outbreak. J Hosp Infect. 2010; 74(4): 370-6[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments